We are live on
!
Find out more
WSA
Wall Street Associates Portfolio holdings
AUM
$151M
1-Year Est. Return
30.3%
This Fund
S&P 500
This Quarter
Est. Return
+0.59%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.16B
AUM Growth
-$60.2M
(-4.9%)
Cap. Flow
-$18.8M
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
14.59%
Holding
356
New
48
Increased
68
Reduced
171
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
+$7.51M |
| 2 |
Orion Group Holdings
ORN
|
+$7.29M |
| 3 |
ZOES
Zoe's Kitchen, Inc.
ZOES
|
+$6.6M |
| 4 |
IMPR
IMPRIVATA, INC COM
IMPR
|
+$6.35M |
| 5 |
Ardelyx
ARDX
|
+$6.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gentherm
THRM
|
+$18.6M |
| 2 |
The Greenbrier Companies
GBX
|
+$13.3M |
| 3 |
DXP Enterprises
DXPE
|
+$11.8M |
| 4 |
POWR
POWERSECURE INTL INC COM STK (DE)
POWR
|
+$8.86M |
| 5 |
AMWD
American Woodmark
AMWD
|
+$8.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.1% |
| 2 | Healthcare | 19.91% |
| 3 | Industrials | 12.49% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Energy | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
201
Crescent Biopharma
CBIO
$610M
| $1.26M | 0.11% |
1,500
| – | – |
|
202
J&J Snack Foods
JJSF
$1.72B
| $1.25M | 0.11% |
+13,294
| New | +$1.25M |
|
203
Lam Research
LRCX
$383B
| $1.23M | 0.11% |
181,970
-9,100
| -5% | -$54.4K |
|
204
Radware
RDWR
$1.17B
| $1.17M | 0.1% |
69,244
-7,100
| -9% | -$120K |
|
205
Stagwell
STGW
$2.23B
| $1.12M | 0.1% |
51,953
-5,700
| -10% | -$128K |
|
206
Ionis Pharmaceuticals
IONS
$9.06B
| $1.11M | 0.1% |
32,172
-3,400
| -10% | -$107K |
|
|
BEE
207
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
| $1.11M | 0.1% |
94,555
-8,780
| -8% | -$94.8K |
|
|
SPLK
208
DELISTED
Splunk Inc
SPLK
| $1.08M | 0.09% |
19,517
+2,696
| +16% | +$141K |
|
|
PETX
209
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.05M | 0.09% |
67,597
-7,700
| -10% | -$109K |
|
210
Eagle Materials
EXP
$6.48B
| $1.05M | 0.09% |
11,169
-1,580
| -12% | -$138K |
|
211
Corpay
CPAY
$26B
| $1.05M | 0.09% |
7,943
-1,260
| -14% | -$154K |
|
212
Capri Holdings
CPRI
$1.72B
| $1M | 0.09% |
11,310
-2,661
| -19% | -$244K |
|
213
Illumina
ILMN
$29.3B
| $987K | 0.08% |
5,683
-1,203
| -17% | -$179K |
|
214
iShares Russell 2000 Growth ETF
IWO
$14.8B
| $969K | 0.08% |
7,000
-29,900
| -81% | -$3.93M |
|
215
Constellation Brands
STZ
$22.6B
| $957K | 0.08% |
10,856
-5,119
| -32% | -$422K |
|
216
Polaris
PII
$3.99B
| $951K | 0.08% |
7,303
-1,070
| -13% | -$142K |
|
217
Thermo Fisher Scientific
TMO
$214B
| $944K | 0.08% |
8,000
| – | – |
|
|
CLUB
218
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $902K | 0.08% |
135,700
-237,300
| -64% | -$1.62M |
|
|
SUNE
219
DELISTED
SUNEDISON, INC COM
SUNE
| $899K | 0.08% |
39,757
-5,400
| -12% | -$105K |
|
220
Bread Financial
BFH
$4.44B
| $886K | 0.08% |
3,949
-62
| -2% | -$12.6K |
|
221
NXP Semiconductors
NXPI
$58.4B
| $850K | 0.07% |
12,842
-9,270
| -42% | -$568K |
|
222
Vulcan Materials
VMC
$36.5B
| $845K | 0.07% |
13,252
-1,770
| -12% | -$112K |
|
|
SIVB
223
DELISTED
SVB Financial Group
SIVB
| $843K | 0.07% |
+7,230
| New | +$806K |
|
224
SBA Communications
SBAC
$19.4B
| $821K | 0.07% |
8,028
-1,180
| -13% | -$113K |
|
|
PXD
225
DELISTED
Pioneer Natural Resource Co.
PXD
| $819K | 0.07% |
3,565
+1,192
| +50% | +$246K |
|
Similar funds
CF
VWM
HH
NSCP
EEG
BC
WRHAM
SRP
Wall Street Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Wall Street Associates held 356 positions worth $1.16B, down 4.9% from $1.22B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wall Street Associates's Q2 2014 filing shows 48 new, 68 increased, 171 reduced and 42 closed positions. Its largest new stake was Pernix Therapeutics Holdings, Inc.: 122,500 shares worth $11M. The largest sale was Gentherm, an estimated $18.6M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Wall Street Associates's largest Q2 2014 buy was Pernix Therapeutics Holdings, Inc.: 122,500 shares worth $11M.
- Wall Street Associates added most to Orion Group Holdings in Q2 2014, an estimated $7.29M increase.
- Wall Street Associates's biggest Q2 2014 reduction was The Greenbrier Companies, cutting an estimated $13.3M.
- Wall Street Associates fully exited Gentherm in Q2 2014, selling an estimated $18.6M.
- Wall Street Associates's ten largest holdings make up 15% of its $1.16B portfolio in Q2 2014.
- Wall Street Associates opened 48 new positions and closed 42 in Q2 2014.
- Wall Street Associates's portfolio value fell 4.9% quarter-over-quarter to $1.16B.
Based on Wall Street Associates's 13F filing for Q2 2014, filed 14 Aug 2014.